Portfolio company
Genezen
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company manufactures viral vectors for biotechnology and pharmaceutical firms developing cell and gene therapies.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Brammer Bio
This contract development and manufacturing organisation produces viral vectors for pharmaceutical and biotechnology companies developing gene and cell therapies.
Fuse Vectors
This company develops a cell-free enzymatic platform to manufacture viral vectors for pharmaceutical and biotechnology clients to produce gene therapies.
Gene Therapy Delivery Methods
This company develops viral and non-viral vector platforms to provide genetic material delivery solutions for biotechnology firms and healthcare providers.
Forge Biologics
This company provides adeno-associated virus manufacturing services and develops gene therapies for biotechnology and pharmaceutical organisations.
SIRION Biotech
The company develops and manufactures viral vector technologies for researchers and pharmaceutical firms in the cell and gene therapy sectors.
ViroCell
The company designs and manufactures viral vectors for academic and corporate innovators developing cell and gene therapies for clinical trials.
Kytopen
This company develops non-viral gene delivery platforms for biotechnology researchers and pharmaceutical manufacturers to accelerate the production of gene-modified cell therapies.
Bitrobius Genetics
This company develops synthetic gene transfer technology for researchers and pharmaceutical firms to manufacture and deliver cell and gene therapies and vaccines.
